It also discussed the latest research progress on the role of PI3K/AKT/mammalian target of rapamycin (mTOR) signaling pathway in cancer development and the inhibitors of molecular targets, especially PI3K and AKT inhibitors. This evidence concerns the gene PIK3CB and cancer.